4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-012397
Director sold 42,377 shares at an average $9.75 ($413,366)
- Director acquired 42,377 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2026-02-24 | Option exercise 10b5-1 | +42,377 | $1.49 | $62,930 | 1,186,768 | D |
| SATO VICKI L Director | 2026-02-24 | Sale 10b5-1 | −42,177 | $9.75 | $411,314 | 1,144,591 | D |
| SATO VICKI L Director | 2026-02-24 | Sale 10b5-1 | −200 | $10.26 | $2,052 | 1,144,391 | D |
| Derivatives | |||||||
| SATO VICKI L Director | 2026-02-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −42,377 | 0 | D | ||
| Open-market sales · 42,377 sh · avg $9.75 · $413,366 | |||||||
Loading xslF345X05/wk-form4_1772142986.xml…